Embarking on the journey from laboratory to the patient, the path of new medicines is complex and multifaceted, extending well beyond the New Drug Application (NDA). This journey encompasses critical stages such as national decision-making, pricing, and reimbursement negotiations—processes that can span years.
In our upcoming webinar, we delve into two pivotal topics: first, we explore how patients can gain access to groundbreaking medicines through compassionate use programs, even when clinical data is limited. Then, we turn our focus to low and middle-income countries, discussing strategies to expedite the national evaluation process for new medicines. Join us to uncover insights into accelerating the delivery of life-saving treatments to those who need them most.
Learning Objectives:
📌 Understand the role of compassionate use programs in providing access to new medicines with limited clinical data.
📌 Explore strategies to expedite the national evaluation process for new medicines in low and middle-income countries.
Click the photo above or this link to register now! Don’t miss out on your chance to engage in this vital discussion.
